Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer

Oncogene

Volumn 16, Issue 7, 1998, Pages 933-943

  Miyake, Hideaki ^a,b   Hanada, Norihisa ^a   Nakamura, Hideo ^a   Kagawa, Shunsuke ^c   Fujiwara, Toshiyoshi ^c   Hara, Isao ^b   Eto, Hiroshi ^b   Gohji, Kazuo ^b   Arakawa, Soichi ^b   Kamidono, Sadao ^b   Saya, Hideyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adenoviral mediated p53 gene transfer; Apoptosis; Bcl 2; Bladder cancer; Cisplatin

Indexed keywords

CISPLATIN; PROPIDIUM IODIDE; PROTEIN P53;

ADENOVIRUS; APOPTOSIS; ARTICLE; BLADDER CANCER; DNA DEGRADATION; FLOW CYTOMETRY; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; MUS MUSCULUS;

EID: 15444340598     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201602     Document Type: Article

References (44)

1. Armstrong DK, Issacs JT, Ottaviano YL and Davidson NE. (1992). Cancer Res., 52, 3418-3424.
2. Bilim V, Tomita Y, Kawasaki T, Katagiri A, Imai T, Takeda M and Takahashi K. (1996). J. Natl. Cancer Inst., 88, 686-688.
3. Chiou S-K, Rao L and White E. (1994). Mol. Cell. Biol., 14, 2556-2563.
4. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
5. Chu G. (1994). J. Biol. Chem., 269, 787-790.
6. Crystal RG. (1995). Science, 270, 404-410.
7. Dive C and Hickman JA. (1991). Br. J. Cancer, 64, 192-196.
8. Eliopoulos AG, Kerr DJ, Herod J, Hodgkins L, Krajewski S, Reed JC and Young LS. (1995). Oncogene, 11, 1217-1228.
9. Feigner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM and Danielsen M. (1987). Proc. Natl. Acad. Sci. USA, 84, 7413-7417.
10. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang W-W, Owen-Schaub LB and Roth JA. (1994). Cancer Res., 54, 2287-2291.
11. Gallo O, Boddi V, Calzolari A, Simonetti L, Trovati M and Bianchi S. (1996). Clin. Cancer Res., 2, 261-267.
12. Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck AP, Roth JA, McDoneel TJ, Steck KD, Leviv VA and Yung WKA. (1996). Cancer Res., 56, 694-699.
13. Graham FL and Prevec L. (1991). Manipulation of adenovirus vectors: Methods in Molecular Biology, Gene Transfer and Expression Protocols. Murray EJ (ed). The Humana Press, Inc.: New Jersey, pp. 109-128.
14. Hamada K, Alemany R, Zhang W-W, Hittelman WN, Lotan R, Roth JA and Mittchell MF. (1996). Cancer Res., 56, 3047-3054.
15. Jayaraman L and Prives C. (1995). Cell, 81, 1021-1029.
16. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S and Saito I. (1995). Nucleic Acids Res., 23, 3816-3821.
17. Kim YH, Proust JJ, Buchholz MJ, Chrest FJ and Nordin AA. (1992). J. Immunol., 149, 17-23.
18. King ED, Mattesen J, Jacobs SC and Kuprianou N. (1996). J. Urol., 155, 316-320.
19. Kyo E, Yokozaki H, Yanagihara K, Yasui W, Ito M, Sano T, Lee PS, Saya H and Tahara E. (1993). Int. J. Oncol., 3, 265-271.
20. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, Joulin V and Kahn A. (1996). Nature Med., 2, 80-86.
21. Lee S, Elenbaas B, Levine A and Griffith J. (1995). Cell, 81, 1013-1020.
22. Liu T-J, El-Nagger AK, McDonnell TJ, Steck KD, Wang M, Taylor DL and Clayman GL. (1995). Cancer Res., 55, 3117-3122.
23. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993). Cell, 74, 957-967.
24. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T. (1994). Science, 266, 807-810.
25. Miyake H, Yoshimura K, Hara I, Eto H, Arakawa S and Kamidono S. (1997). J. Urol., 157, 2351-2355.
26. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger V, McKearn JP and Korsemeyer SJ. (1989). Cell, 57, 79-88.
27. Mujoo K, Maneval DC, Anderson SC and Gutterman JU. (1996). Oncogene, 12, 1617-1623.
28. Murphy AJM, Kung AL, Swirski RA and Schímke RT. (1992). Meth. Comparison Meth. Enzymol., 4, 111-131.
29. Oldfield EH, Ram Z, Culver BW, Blaese RM, Devroom HL and Anderson WF. (1993). Human Gene Ther., 4, 39-69.
30. Park JG, Kramer BS, Steinberg SM, Carmichael J, Collins JM, Minna JD and Gazdar AF. (1987). Cancer Res., 47, 5875-5879.
31. Parker SL, Tong T, Bolden S and Wingo PA. (1996). CA Cancer J. Clin., 65, 5-27.
32. Raffo AJ, Perlman H, Chen M-W, Day ML, Streitman JS and Buttyan R. (1995). Cancer Res., 55, 4438-4445.
33. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T and Cai D. (1996). Nature Med., 2, 985-991.
34. Rousculp MD, Goldsmith KT and Carver RI. (1992). Human Gene Ther., 3, 471-477.
35. Sternberg CN, Arena MG, Calabresi FC, Carli PD, Platania A, Massimo Z, Giannarelli D, Cancrini A and Pansadoro V. (1993). Cancer, 72, 1975-1982.
36. Thrasher JB and Crawford ED. (1993). J. Urol., 149, 957-961.
37. Tomita Y, Bilim V, Kawasaki T, Takahashi K, Okan I, Magnusson KP and Wiman KG. (1996). Int. J. Cancer, 66, 322-325.
38. Tsujimoto Y, Cossman JJ and Croce CM. (1985). Science, 228, 1440-1443.
39. Tsujimoto Y. (1989). Oncogene, 4, 1331-1336.
40. Vaux DL, Cory S and Adams JM. (1988). Nature, 335, 440-442.
41. Wang Y, Szekely L, Okan I, Klein G and Wiman KG. (1993). Oncogene, 8, 3427-3431.
42. Welsh MJ, Smith AE, Zabner J, Rich DP, Graham SM, Gregory RJ, Pratt BM and Moscicki RA. (1994). Human Gene Ther., 5, 209-219.
43. Werthman PE, Drazan KE, Rosenthal JT, Khalili R and Shaked A. (1996). J. Urol., 155, 753-756.
44. Zhang WW, Fang X, Branch CD, Mazur W, French BA and Roth JA. (1993). Biotechniques, 15, 868-872.